Actinium Pharmaceuticals
ATNM
#9685
Rank
A$61.27 M
Marketcap
$1.96
Share price
-0.81%
Change (1 day)
-76.59%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2024 (TTM): -A$66.68 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are A$0.08 Million. In 2023 the company made an earning of -A$83.59 Million a decrease over its 2022 earnings that were of -A$54.91 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$66.68 Million-20.23%
2023 -A$83.59 Million52.24%
2022 -A$54.91 Million36.61%
2021 -A$40.19 Million11.48%
2020 -A$36.05 Million1.46%
2019 -A$35.54 Million-7.37%
2018 -A$38.36 Million-11.46%
2017 -A$43.33 Million10.67%
2016 -A$39.15 Million15.7%
2015 -A$33.84 Million-14.86%
2014 -A$39.75 Million129.19%
2013 -A$17.35 Million-8.55%
2012 -A$18.97 Million
2010 A$0.01 M-152.15%
2009 -A$0.03 Million-39.8%
2008 -A$0.05 Million120.29%
2007 -A$0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$59.88 Million-17.28%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.63 B-970.68%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.12 Billion 52.03%๐Ÿ‡บ๐Ÿ‡ธ USA